Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with probable Parkinson's Disease based on recognised medical guidelines.
- You are currently taking levodopa (a common Parkinson's medication) at a dose of at least 300 mg per day.
- You scored 15 or higher on a standard memory and thinking test called the Montreal Cognitive Assessment.
- You are able to understand and agree to take part in the study on your own.
- You are between 40 and 90 years of age.
- Your kidneys are working at a sufficient level, based on a blood test result (confirm with trial site).
- You do not have a history of uncontrolled high blood pressure.
- You are not currently using insulin.
Who may not be able to join:
- No specific exclusion criteria have been listed for this trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joseph Quinn, MD, Oregon Health & Science University (OHSU)
Phone: 503-501-8478
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Hyperhomocysteinemia and B vitamin deficiency; Hyperhomocysteinemia and B vitamin deficiency; Hyperhomocysteinemia and B vitamin deficiency
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.